Dong-A, Kwangdong Pharma to benefit from OTC sales at supermakets
Published: 2011-06-15 06:57:00
Updated: 2011-06-15 06:57:00
Shares of Dong-A Pharmaceutical and Kwangdong Pharmaceutical are expected to be boosted by expectations that their flagship products, Bacchus and Ssanwhatang drinks, may be reclassified into quasi-drugs, according to market watchers.
The Ministry of Health and Welfare said Thursday that it wou...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
